{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:35Z","timestamp":1790222855359,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Drug Abuse-NIH","award":["R01 DA037773"],"award-info":[{"award-number":["R01 DA037773"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Despite high hepatitis C virus (HCV) treatment rates, HCV incidence among human immunodeficiency virus (HIV)\u2013infected men who have sex with men (HIV-infected MSM) in Germany rose before HCV direct-acting antivirals (DAAs). We model what intervention can achieve the World Health Organization (WHO) elimination target of an 80% reduction in HCV incidence by 2030 among HIV-infected MSM in Berlin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An HCV transmission model among HIV-diagnosed MSM was calibrated to Berlin (rising HCV incidence and high rates of HCV testing and treatment). We modeled the HCV incidence among HIV-diagnosed MSM in Berlin until 2030 (relative to 2015 WHO baseline) under scenarios of DAA scale-up with or without behavior change (among HIV-diagnosed MSM and\/or all MSM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Continuing current treatment rates will marginally reduce the HCV incidence among HIV-diagnosed MSM in Berlin by 2030. Scaling up DAA treatment rates, beginning in 2018, to 100% of newly diagnosed HCV infections within 3 months of diagnosis and 25% each year of previously diagnosed and untreated HCV infections could reduce the HCV incidence by 61% (95% confidence interval, 55.4%\u201366.7%) by 2030. The WHO target would likely be achieved by combining DAA scale-up with a 40% reduction in HCV transmission among HIV-diagnosed MSM and a 20% reduction among HIV-undiagnosed or HIV-uninfected MSM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>HCV elimination among HIV-infected MSM in Berlin likely requires combining DAA scale-up with moderately effective behavioral interventions to reduce risk among all MSM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiz367","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T19:09:19Z","timestamp":1562872159000},"page":"1635-1644","source":"Crossref","is-referenced-by-count":33,"title":["Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus\u2013Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis"],"prefix":"10.1093","volume":"220","author":[{"given":"Natasha K","family":"Martin","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Jansen","sequence":"first","affiliation":[{"name":"Robert-Koch Institut, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"an der Heiden","sequence":"first","affiliation":[{"name":"Robert-Koch Institut, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Boesecke","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Boyd","sequence":"first","affiliation":[{"name":"INSERM, Paris, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, France"},{"name":"Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knud","family":"Schewe","sequence":"first","affiliation":[{"name":"Infektionsmedizinisches Centrum Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Baumgarten","sequence":"first","affiliation":[{"name":"Center for Infectiology, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lutz","sequence":"first","affiliation":[{"name":"Infektiologikum, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Christensen","sequence":"first","affiliation":[{"name":"Centrum f\u00fcr Innere Medizin, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thielen","sequence":"first","affiliation":[{"name":"Insitute for Immunology and Genetics, Kaiserslautern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mauss","sequence":"first","affiliation":[{"name":"Center for HIV and Hepatogastroenterology, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen K","family":"Rockstroh","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Skaathun","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ingiliz","sequence":"first","affiliation":[{"name":"Center for Infectiology, Berlin, Germany"},{"name":"Department of Hepatology and Gastroenterology, Charit\u00e9 University Medical Center Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2020071416123233400_CIT0001","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"key":"2020071416123233400_CIT0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"2020071416123233400_CIT0003","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2020071416123233400_CIT0004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2020071416123233400_CIT0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2017.03.038","article-title":"Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014","volume":"67","author":"van Santen","year":"2017","journal-title":"J Hepatol"},{"key":"2020071416123233400_CIT0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142515","article-title":"High prevalence and high incidence of coinfection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany","author":"Jansen","year":"2015","journal-title":"PLoS One"},{"key":"2020071416123233400_CIT0007","article-title":"Global health sector strategy on viral hepatitis, 2016\u20132021","author":"World Health Organization","year":"2016"},{"key":"2020071416123233400_CIT0008","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/ciw219","article-title":"Management of hepatitis C\/HIV coinfection in the era of highly effective hepatitis C virus direct-acting antiviral therapy","volume":"63","author":"Wyles","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020071416123233400_CIT0009","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"key":"2020071416123233400_CIT0010","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/S2352-3018(18)30299-6","article-title":"Microelimination could be a big deal for HCV and HIV services","volume":"5","author":"The Lancet H","year":"2018","journal-title":"Lancet HIV"},{"key":"2020071416123233400_CIT0011","author":"British HIV Association"},{"key":"2020071416123233400_CIT0012","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciw075","article-title":"Can hepatitis C virus (HCV) direct-acting antiviral treatment as prevention reverse the HCV epidemic among men who have sex with men in the United Kingdom? epidemiological and modeling insights","volume":"62","author":"Martin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020071416123233400_CIT0013","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.28769","article-title":"Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: modeling the effect of behavioral and treatment interventions","volume":"64","author":"Salazar-Vizcaya","year":"2016","journal-title":"Hepatology"},{"key":"2020071416123233400_CIT0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jvh.12752","article-title":"On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: a mathematical modelling study","volume":"25","author":"Salazar-Vizcaya","year":"2018","journal-title":"J Viral Hepat"},{"key":"2020071416123233400_CIT0015","doi-asserted-by":"crossref","first-page":"e25059","DOI":"10.1002\/jia2.25059","article-title":"Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour","volume":"21","author":"Scott","year":"2018","journal-title":"J Intern AIDS Soc"},{"key":"2020071416123233400_CIT0016","article-title":"Can Australia reach the World Health Organization hepatitis C elimination goal by 2025 among HIV-positive gay and bisexual men?","author":"Boettiger","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020071416123233400_CIT0017","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2016.09.004","article-title":"HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe","volume":"66","author":"Ingiliz","year":"2017","journal-title":"J Hepatol"},{"key":"2020071416123233400_CIT0018","article-title":"Estimation of new infections with HIV and the number of persons living with HIV in Germany at end of 2016 [in German]","volume":"47:531\u2013544","author":"an der Heiden","year":"2017","journal-title":"Epid Bull"},{"key":"2020071416123233400_CIT0019","author":"Yin"},{"key":"2020071416123233400_CIT0020","doi-asserted-by":"crossref","first-page":"d6016","DOI":"10.1136\/bmj.d6016","article-title":"Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study","volume":"343","author":"May","year":"2011","journal-title":"BMJ"},{"key":"2020071416123233400_CIT0021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e32834dcec9","article-title":"Projected life expectancy of people with HIV according to timing of diagnosis","volume":"26","author":"Nakagawa","year":"2012","journal-title":"AIDS"},{"key":"2020071416123233400_CIT0022","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2012.12.026","article-title":"Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997","volume":"144","author":"van der Helm","year":"2013","journal-title":"Gastroenterology"},{"key":"2020071416123233400_CIT0023","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"2020071416123233400_CIT0024","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"Thomson","year":"2011","journal-title":"Gut"},{"key":"2020071416123233400_CIT0025","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hep.23959","article-title":"Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study","volume":"52","author":"Piroth","year":"2010","journal-title":"Hepatology"},{"key":"2020071416123233400_CIT0026","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jvh.12707","article-title":"HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C","volume":"24","author":"Steininger","year":"2017","journal-title":"J Viral Hepat"},{"key":"2020071416123233400_CIT0027","article-title":"Does the availability of new DAAs influence treatment uptake in acute hepatitis C in HIV coinfection?","author":"Boesecke"},{"key":"2020071416123233400_CIT0028","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s15010-015-0856-9","article-title":"Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome","volume":"44","author":"Boesecke","year":"2016","journal-title":"Infection"},{"key":"2020071416123233400_CIT0029","doi-asserted-by":"crossref","first-page":"e55373","DOI":"10.1371\/journal.pone.0055373","article-title":"Treatment outcomes of treatment-na\u00efve hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts","volume":"8","author":"Davies","year":"2013","journal-title":"PLoS One"},{"key":"2020071416123233400_CIT0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/2050640617716607","article-title":"Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting","volume":"6","author":"H\u00f6ner zu Siederdissen","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"2020071416123233400_CIT0031","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"key":"2020071416123233400_CIT0032","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/sextrans-2012-050566","article-title":"Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review","volume":"88","author":"Yaphe","year":"2012","journal-title":"Sex Transm Infect"},{"key":"2020071416123233400_CIT0033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2016.09.007","article-title":"Illicit drug use among gay and bisexual men in 44 cities: findings from the European MSM Internet Survey (EMIS)","volume":"38","author":"Schmidt","year":"2016","journal-title":"Int J Drug Policy"},{"key":"2020071416123233400_CIT0034","first-page":"421","article-title":"Sexual risk behavior, sexually transmitted infections, and HIV transmission risks in HIV-positive men who have sex with men (MSM)\u2014approaches for medical prevention","volume":"15","author":"Esser","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"key":"2020071416123233400_CIT0035","first-page":"15","article-title":"Sexualised drug use by MSM (ChemSex): a toolkit for GUM\/HIV staff","volume":"14","author":"Stuart","year":"2014","journal-title":"HIV Nursing"},{"key":"2020071416123233400_CIT0036","volume-title":"EMIS 2010: the European men-who-have-sex-with-men internet survey, findings from 38 countries","author":"EMIS Network.","year":"2013"},{"key":"2020071416123233400_CIT0037","first-page":"CD012021","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020071416123233400_CIT0038","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12954-016-0125-y","article-title":"Drug use and health behaviour among German men who have sex with men: results of a qualitative, multi-centre study","volume":"13","author":"Deimel","year":"2016","journal-title":"Harm Reduct J"},{"key":"2020071416123233400_CIT0039","doi-asserted-by":"crossref","first-page":"e0190340","DOI":"10.1371\/journal.pone.0190340","article-title":"Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men","volume":"13","author":"Charre","year":"2018","journal-title":"PLoS One"},{"key":"2020071416123233400_CIT0040","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/liv.13922","article-title":"Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men","volume":"38","author":"Cotte","year":"2018","journal-title":"Liver International"},{"key":"2020071416123233400_CIT0041","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/infdis\/jiy670","article-title":"Sexually acquired hepatitis C infection in HIV-uninfected men who have sex with men using preexposure prophylaxis against HIV","volume":"219","author":"Price","year":"2019","journal-title":"J Infect Dis"},{"key":"2020071416123233400_CIT0042","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/j.gastro.2009.06.040","article-title":"Coinfection with HIV-1 and HCV\u2013a one-two punch","volume":"137","author":"Kim","year":"2009","journal-title":"Gastroenterology"},{"key":"2020071416123233400_CIT0043","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/ije\/dyx075","article-title":"Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact","volume":"46","author":"MacGregor","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2020071416123233400_CIT0044","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/cix1007","article-title":"Declining hepatitis C virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy","volume":"66","author":"Boerekamps","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020071416123233400_CIT0045","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020071416123233400_CIT0046","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/add.13948","article-title":"Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic","volume":"113","author":"Fraser","year":"2018","journal-title":"Addiction"},{"key":"2020071416123233400_CIT0047","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/QAD.0000000000001789","article-title":"Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV","volume":"32","author":"Pradat","year":"2018","journal-title":"AIDS"},{"key":"2020071416123233400_CIT0048","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.27403","article-title":"The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs","volume":"60","author":"Hellard","year":"2014","journal-title":"Hepatology"},{"key":"2020071416123233400_CIT0049","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1473-3099(17)30676-X","article-title":"Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study","volume":"18","author":"Zelenev","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz367\/29214348\/jiz367.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/10\/1635\/33495786\/jiz367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/10\/1635\/33495786\/jiz367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T20:12:50Z","timestamp":1594757570000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/10\/1635\/5532024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,7,12]]},"published-print":{"date-parts":[[2019,10,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz367","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,15]]},"published":{"date-parts":[[2019,7,12]]}}}